Pirfenidone in post-COVID-19 pulmonary fibrosis (FIBRO-COVID): a phase 2 randomised clinical trial.
Bermudo-Peloche G, Del Rio B, Vicens-Zygmunt V, Bordas-Martinez J, Hernández M, Valenzuela C, Laporta R, Rigual Bobillo J, Portillo K, Millán-Billi P, Balcells E, Badenes-Bonet D, Bolivar S, Rodríguez-Portal JA, López Ramirez C, Tomás L, Fernández de Roitegi K, Sellarés J, Castillo D, González J, Barril S, Gutiérrez-Rodríguez Y, Caballero P, Alarcon J, Peñafiel J, Sanz-Santos J, Blavia R, Caupena C, Segovia P, Santos-Pérez S, Ferrer-Artola A, Badia MB, Hereu P, Fuentes M, Montes-Worboys A, Franquet T, Luburich P, Molina-Molina M.
Bermudo-Peloche G, et al. Among authors: balcells e.
Eur Respir J. 2025 Apr 24;65(4):2402249. doi: 10.1183/13993003.02249-2024. Print 2025 Apr.
Eur Respir J. 2025.
PMID: 40154560
Free PMC article.
Clinical Trial.